Dr. Ari Benjamin Molofsky, MD, PhD

Dr. Molofsky practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Molofsky's NPI, 1104151984, was assigned on October 12, 2009. Dr. Molofsky graduated from University Of Michigan Medical School in 2007. Dr. Molofsky holds California license A107555.

Dr. Molofsky's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Molofsky's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Molofsky to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Molofsky practices. Vendor and product names are available with a free account.

Clinical pathology/laboratory medicine is Dr. Molofsky's primary specialty in the NPI Registry, under taxonomy code 207ZP0105X. Dr. Molofsky is board certified in hematopathology by the American Board of Pathology. Dr. Molofsky is licensed in California.

CMS data shows 16 Medicare services from Dr. Molofsky across 1 procedure code in 2024, for 29 Medicare patients. Medicare paid $320 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 29 Medicare patients who saw Dr. Molofsky in 2024. The largest group is 65 to 74, with 12 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 41% are also on Medicaid. Their average risk score is 2.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Molofsky's median patient age at 46, with 44% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Molofsky for performance year 2024, reported as part of a group. Dr. Molofsky accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 43 papers to Dr. Molofsky, published from 2003 to 2025. 2019 was the busiest year, with 4. The most frequent topics are Immunity, Innate, Lymphocytes and Mice, Inbred C57BL. Dr. Molofsky has published most often in Immunity. Dr. Molofsky's most frequent co-authors are Richard M. Locksley, MD, Anna Victoria Rotberg Molofsky, MD and Jesse Charles Nussbaum, MD.

CMS Open Payments shows 4 general payments to Dr. Molofsky from 2 drug and device companies from 2022 to 2025. Consulting fees make up the largest share, 69% of the total. Genentech, Inc. paid the most, $2,501.

Dr. Molofsky graduated from University Of Michigan Medical School in 2007.

Dr. Molofsky is in network with 2 carriers, including United Healthcare and CMS Medicare. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.